Every one of those 1 sits in a single category, market-trends. ANI Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 5.6.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Alpha Metallurgical
Every one of those 1 sits in a single category, market-trends. ANI Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 5.6. They are less corroborated than the beat average, carrying 4 original sources each against 4.7 for the same window. We currently track 1 Healthcare story that mention Alpha Metallurgical, all published on February 26, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Alpha Metallurgical. Shared-story counts are live from our verified record — not editorial picks.
ANI Pharmaceuticals and Amneal Pharmaceuticals are preparing to report Q4 2025 results, with ANI expected to show significant double-digit growth in both revenue and earnings. These reports will provide a critical pulse check on the specialty generics market and the impact of recent portfolio expansions.